Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 29.95 0.6 (2.04%) Market Cap: 1.70 Bil Enterprise Value: 1.52 Bil PE Ratio: 12.97 PB Ratio: 3.30 GF Score: 63/100

Q1 2022 Harmony Biosciences Holdings Inc Earnings Call Transcript

May 03, 2022 / 12:30PM GMT
Release Date Price: $37.18 (-17.56%)
Operator

Good morning. My name is Ashley, and I will be your conference operator today. At this time, I would like to welcome everyone to the Harmony Biosciences First Quarter 2022 Financial Update Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I will now turn the call over to Luis Sanay, Head of Investor Relations. Please go ahead.

Luis Sanay

Thank you, operator. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences first quarter 2022 financial performance and provide a business update. Before we start, I encourage everyone to go to the Investors section of our website to find the press release and slides that accompany our discussion today, including a reconciliation of our GAAP to non-GAAP financial measures. At this stage of our lifecycle, we believe non-GAAP financial results better represent the underlying business performance.

Our presenters on today's call are John Jacobs, President and CEO; Dr. Jeffrey Dayno, Chief Medical Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot